Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 57
Filter
1.
Mol Cell Pediatr ; 3(1): 4, 2016 Dec.
Article in English | MEDLINE | ID: mdl-26830109

ABSTRACT

UNLABELLED: ᅟ: Starch requires six enzymes for digestion to free glucose: two amylases (salivary and pancreatic) and four mucosal maltase activities; sucrase-isomaltase and maltase-glucoamylase. All are deficient in suckling rodents. OBJECTIVE: The objective of this study is to test (13)C-starch digestion before weaning by measuring enrichment of blood (13)C-glucose in maltase-glucoamylase-null and wild-type mice. METHODS: Maltase-glucoamylase gene was ablated at the N-terminal. Dams were fed low (13)C-diet and litters kept on low (13)C-diet. Pups were weaned at 21 days. Digestion was tested at 13 and 25 days by intragastric feeding of amylase predigested (13)C-α-limit dextrins. Blood (13)C-glucose enrichment was measured by gas chromatography combustion isotope ratio mass spectrometry (GCRMS) using penta-acetate derivatives. RESULTS: Four hours after feeding, blood (13)C-glucose was enriched by 26 × 10(3) in null and 18 × 10(3) in wild-type mice at 13 days and 0.3 × 10(3) and 0.2 × 103 at 25 days (vs. fasting p = 0.045 and p = 0.045). By jejunal enzyme assay, immunohistochemistry, or Western blots, there was no maltase activity or brush border staining with maltase-glucoamylase antibodies at 13 days, but these were fully developed in the wild-type mice by 25 days. In 13-day null mice, luminal contents were stained by maltase-glucoamylase antibodies. Lactating the mammary gland revealed maltase-glucoamylase antibody staining of alveolar cells. Reverse transcription/polymerase chain reaction (RT/PCR) of lactating glands revealed a secreted form of maltase-glucoamylase. CONCLUSIONS: (1) (13)C-α-limit dextrins were rapidly digested to (13)C-glucose in 13-day mice independent of maltase-glucoamylase genotype or mucosal maltase activity. (2) This experiment demonstrates that a soluble maltase activity is secreted in mouse mother's milk which enables suckling pup starch digestion well before brush border enzyme development. (3) This experiment with (13)C-α-limit dextrins needs to be repeated in human breast fed infants.

4.
J Pediatr Gastroenterol Nutr ; 31(3): 264-9, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10997370

ABSTRACT

BACKGROUND: Undernutrition is common in patients with cystic fibrosis (CF). Nutritional rehabilitation has been shown to improve linear growth, pulmonary function, well-being, and resistance to infection in this population. The purpose of this study was to determine whether the administration of megestrol acetate (MA) induces weight gain in malnourished patients with CF, and to assess the composition of weight gain. METHODS: In a randomized, placebo-controlled, double-blind, crossover study, 12 children with CF received MA (10 mg/kg/d) or placebo for 12 weeks, followed by a 12-week washout period, then the alternative treatment. Anthropometrics, caloric intake, and clinical assessment were obtained every 6 weeks; pulmonary function tests, biochemistry, hematology, cortisol, growth hormone, insulin, C-peptide, insulin-like growth factor-1, insulin-like growth factor binding protein-3, and dual-energy x-ray absorptiometry scans were obtained every 12 weeks. RESULTS: Six children did not complete the study, three for reasons unrelated to the study, two because they developed diabetes while receiving MA, and one who had glucose intolerance while receiving the placebo. Average weight gain was 3.05 kg in the MA group and 0.3 kg in the placebo group. The change in weight z score was +0.76 in the MA group and -0.05 in the placebo group. The change in height z score was -0.06 in the MA group and +0.06 in the placebo group. Lean body mass and body fat increased by 1507 g and 1192 g respectively in the MA group. Pulmonary function tests improved in the MA group; serum cortisol levels decreased. Side effects included glucosuria, insomnia, hyperactivity, and irritability. CONCLUSIONS: Weight, body fat, and lean body mass increased and pulmonary function improved in the children with CF given MA. Adrenal suppression, glucose intolerance, and diabetes are side effects.


Subject(s)
Body Composition/drug effects , Cystic Fibrosis/complications , Megestrol Acetate/therapeutic use , Nutrition Disorders/drug therapy , Weight Gain/drug effects , Adolescent , Anthropometry , Cachexia/drug therapy , Child , Child, Preschool , Cystic Fibrosis/drug therapy , Double-Blind Method , Energy Intake/drug effects , Female , Glucose/metabolism , Humans , Infant , Male , Megestrol Acetate/adverse effects , Megestrol Acetate/pharmacology , Nutrition Disorders/complications , Respiratory Function Tests
5.
Am J Physiol Gastrointest Liver Physiol ; 279(2): G332-40, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10915642

ABSTRACT

The role of H(2)O(2) and protein thiol oxidation in oxidative stress-induced epithelial paracellular permeability was investigated in Caco-2 cell monolayers. Treatment with a H(2)O(2) generating system (xanthine oxidase + xanthine) or H(2)O(2) (20 microM) increased the paracellular permeability. Xanthine oxidase-induced permeability was potentiated by superoxide dismutase and prevented by catalase. H(2)O(2)-induced permeability was prevented by ferrous sulfate and potentiated by deferoxamine and 1,10-phenanthroline. GSH, N-acetyl-L-cysteine, dithiothreitol, mercaptosuccinate, and diethylmaleate inhibited H(2)O(2)-induced permeability, but it was potentiated by 1,3-bis(2-chloroethyl)-1-nitrosourea. H(2)O(2) reduced cellular GSH and protein thiols and increased GSSG. H(2)O(2)-mediated reduction of GSH-to-GSSG ratio was prevented by ferrous sulfate, GSH, N-acetyl-L-cysteine, diethylmaleate, and mercaptosuccinate and potentiated by 1,10-phenanthroline and 1, 3-bis(2-chloroethyl)-1-nitrosourea. Incubation of soluble fraction of cells with GSSG reduced protein tyrosine phosphatase (PTPase) activity, which was prevented by coincubation with GSH. PTPase activity was also lower in H(2)O(2)-treated cells. This study indicates that H(2)O(2), but not O(2)(-). or.OH, increases paracellular permeability of Caco-2 cell monolayer by a mechanism that involves oxidation of GSH and inhibition of PTPases.


Subject(s)
Glutathione/metabolism , Hydrogen Peroxide/pharmacology , Oxidants/pharmacology , Protein Tyrosine Phosphatases/antagonists & inhibitors , Acetylcysteine/pharmacology , Antineoplastic Agents, Alkylating/pharmacology , Caco-2 Cells , Carmustine/pharmacology , Catalase/pharmacology , Cell Membrane Permeability/drug effects , Cell Membrane Permeability/physiology , Chelating Agents/pharmacology , Deferoxamine/pharmacology , Free Radical Scavengers/pharmacology , Glutathione/pharmacology , Humans , Intestinal Mucosa/metabolism , Intestines/cytology , Iron/pharmacology , Maleates/pharmacology , Oxidation-Reduction , Phenanthrolines/pharmacology , Protein Tyrosine Phosphatases/metabolism , Protein-Tyrosine Kinases/metabolism , Signal Transduction/physiology , Sulfhydryl Compounds/metabolism , Superoxide Dismutase/pharmacology , Thiomalates/pharmacology , Tight Junctions/enzymology , Vitamin A/pharmacology , Vitamin E/pharmacology
6.
J Pediatr Gastroenterol Nutr ; 29(5): 612-26, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10554136

ABSTRACT

BACKGROUND: Constipation, defined as a delay or difficulty in defecation, present for 2 or more weeks, is a common pediatric problem encountered by both primary and specialty medical providers. METHODS: The Constipation Subcommittee of the Clinical Guidelines Committee of the North American Society for Pediatric Gastroenterology and Nutrition has formulated clinical practice guidelines for the management of pediatric constipation. The Constipation Subcommittee, consisting of two primary care pediatricians, a clinical epidemiologist, and pediatric gastroenterologists, based its recommendations on an integration of a comprehensive and systematic review of the medical literature combined with expert opinion. Consensus was achieved through Nominal Group Technique, a structured quantitative method. RESULTS: The Subcommittee developed two algorithms to assist with medical management, one for older infants and children and the second for infants less than 1 year of age. The guidelines provide recommendations for management by the primary care provider, including evaluation, initial treatment, follow-up management, and indications for consultation by a specialist. The Constipation Subcommittee also provided recommendations for management by the pediatric gastroenterologist. CONCLUSIONS: This report, which has been endorsed by the Executive Council of the North American Society for Pediatric Gastroenterology and Nutrition, has been prepared as a general guideline to assist providers of medical care in the evaluation and treatment of constipation in children. It is not intended as a substitute for clinical judgment or as a protocol for the management of all patients with this problem.


Subject(s)
Constipation/etiology , Constipation/therapy , Child , Child, Preschool , Constipation/diagnostic imaging , Hirschsprung Disease , Humans , Infant , Infant, Newborn , Medical History Taking , Physical Examination , Radiography , Referral and Consultation
7.
Pediatrics ; 104(5 Pt 1): 1152-7, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10545566

ABSTRACT

This statement is intended to provide pediatric caregivers with advice about the nutritional needs of calcium of infants, children, and adolescents. It will review the physiology of calcium metabolism and provide a review of the data about the relationship between calcium intake and bone growth and metabolism. In particular, it will focus on the large number of recent studies that have identified a relationship between childhood calcium intake and bone mineralization and the potential relationship of these data to fractures in adolescents and the development of osteoporosis in adulthood. The specific needs of children and adolescents with eating disorders are not considered.


Subject(s)
Calcium, Dietary/administration & dosage , Child Nutritional Physiological Phenomena , Adolescent , Child , Child, Preschool , Humans , Infant , Infant, Newborn , Nutritional Requirements
8.
Anaesthesia ; 54(10): 953-7, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10540059

ABSTRACT

In order to assess preparedness for the Millennium, we carried out a telephone survey of all Intensive Care Units in the former Northern Region. The survey disclosed wide variation in the current and planned provision of back-up power and central services, proposed staffing levels and expected demand.


Subject(s)
Computer Systems , Equipment Failure , Intensive Care Units/organization & administration , Chronology as Topic , Data Collection , England , Equipment and Supplies, Hospital/standards , Forecasting , Humans , Monitoring, Physiologic/instrumentation , Respiration, Artificial/instrumentation , Software , Time
10.
Biochem Pharmacol ; 57(6): 685-95, 1999 Mar 15.
Article in English | MEDLINE | ID: mdl-10037455

ABSTRACT

The effect of epidermal growth factor (EGF) on the H202-induced increase in paracellular permeability in Caco-2 and T-84 cell monolayers was evaluated to examine the role of EGF in intestinal mucosal protection from oxidative stress. Oxidative stress was induced by exposing cell monolayers to H2O2 or a mixture of xanthine oxidase + xanthine (XO + X). Paracellular permeability was assessed by measuring transepithelial electrical resistance (TER), sodium chloride dilution potential, and unidirectional flux of [3H]mannitol. H2O2 (0.1 to 5.0 mM) reduced TER and dilution potential and increased mannitol flux. Administration of EGF delayed H2O2 and XO + X-induced changes in TER, dilution potential, and [3H]mannitol flux. This protective effect of apically or basally administered EGF was concentration-related, with A50 (95% confidence limits) values of 2.1 (1.17 to 4.34) and 6.0 (4.37 to 8.34) nM, respectively. The EGF-mediated protection was prevented by treatment of cell monolayers with genistein (10 microM), a tyrosine kinase inhibitor. H2O2 and XO + X also induced tyrosine phosphorylation of a number of proteins in Caco-2 and T-84 cell monolayers. EGF treatment inhibited the oxidant-induced tyrosine phosphorylation of proteins, particularly those with a molecular mass of 110-220 kDa. Treatment of Caco-2 cells with anti-transforming growth factor-alpha antibodies potentiated the H2O2-induced changes in TER, dilution potential, and mannitol flux. These studies demonstrated that an EGF receptor-mediated mechanism delays oxidant-induced disruption of the epithelial barrier function, possibly by suppressing the oxidant-induced tyrosine phosphorylation of proteins.


Subject(s)
Epidermal Growth Factor/pharmacology , Protein-Tyrosine Kinases/antagonists & inhibitors , Antibodies, Monoclonal/administration & dosage , Antibodies, Monoclonal/pharmacology , Caco-2 Cells , Electric Impedance , Humans , Hydrogen Peroxide/antagonists & inhibitors , Mannitol/metabolism , Oxidants/antagonists & inhibitors , Protein-Tyrosine Kinases/biosynthesis , Transforming Growth Factor alpha/immunology , Xanthine , Xanthine Oxidase
11.
J Pediatr Gastroenterol Nutr ; 27(4): 387-92, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9779964

ABSTRACT

BACKGROUND: Selenium is located at the catalytic site of the enzyme glutathione peroxidase, and with selenium deficiency the activity of glutathione peroxidase is decreased. Cell culture is an important tool for studying oxidative processes-that is generation and metabolism of oxygen-derived metabolites in the gastrointestinal system. Cell culture is also used to understand the mechanisms of cell injury by oxygen-derived metabolites. METHODS: To assess the importance of the selenium content of cell culture media, Caco-2 cells and the hepatoma-derived cell lines, Hep3B and HepG2, were grown to confluence and placed in media with various concentrations of selenium. After 7 to 14 days, cells were harvested and assayed for glutathione peroxidase, lactate dehydrogenase, and protein content. RESULTS: Cells maintained in media unsupplemented with selenium demonstrated a progressive decrease in glutathione peroxidase activity. Cells maintained in media supplemented with various concentrations of selenium demonstrated a dose-dependent increase in glutathione peroxidase until a plateau was reached. The plateau was reached at approximately 400 times the selenium concentration routinely used in cell culture. In the Caco-2 and hepatoma cells, no toxicity was observed at selenium supplementation five times the lowest concentration needed to reach a plateau. CONCLUSIONS: Cell culture media are routinely deficient in selenium, and cells that are cultured in this medium are deficient in glutathione peroxidase activity. Studies of oxidative metabolism based on cultures deficient in selenium may yield results that could be falsely interpreted. The addition of 1 nM selenium is sufficient for these cell lines to reach a plateau for intracellular glutathione peroxidase activity. These observations may have important ramifications for the study of reactive oxygen metabolite injury in cell culture.


Subject(s)
Culture Media , Glutathione Peroxidase/metabolism , Selenium/administration & dosage , Caco-2 Cells/metabolism , Carcinoma, Hepatocellular/metabolism , Humans , Kinetics , L-Lactate Dehydrogenase/metabolism , Liver Neoplasms/metabolism , Oxidation-Reduction , Proteins/metabolism , Tumor Cells, Cultured
12.
Gastrointest Endosc Clin N Am ; 8(3): 669-703, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9654575

ABSTRACT

Enteral feeding, the provision of liquid nutrients into the gastrointestinal tract, is an important component of pediatric care. For the infant or child with a functioning or even a partially-functioning GI tract, the use of the enteral route provides a safe and efficient means of delivering nutrition at a time of life when requirements are extremely high. In addition to high nutrient requirements in the early years of life, there are a number of specific pediatric conditions, such as failure to thrive, short bowel syndrome, and congenital heart disease, which place further demands on the growing child. These demands can be met through the careful use of enteral feeds. This article reviews the physiology and practical application of enteral feeding to the pediatric age group.


Subject(s)
Enteral Nutrition , Adolescent , Brain Diseases/therapy , Child , Child Nutritional Physiological Phenomena , Child, Preschool , Chronic Disease , Contraindications , Cystic Fibrosis/therapy , Digestive System Physiological Phenomena , Enteral Nutrition/adverse effects , Enteral Nutrition/instrumentation , Enteral Nutrition/methods , Equipment Failure , Failure to Thrive/therapy , Food, Formulated/analysis , HIV Infections/therapy , Heart Defects, Congenital/therapy , Humans , Infant , Infant Nutritional Physiological Phenomena , Kidney Diseases/therapy , Liver Diseases/therapy , Neoplasms/therapy , Nutrition Assessment , Nutritional Requirements , Short Bowel Syndrome/therapy
13.
J Pediatr Gastroenterol Nutr ; 27(1): 1-5, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9669718

ABSTRACT

BACKGROUND: Malnutrition associated with diarrhea and vomiting can be prevented if the focus of treatment is on nutritional requirements. Some pediatricians inappropriately continue to recommend clear liquids followed by dilute feedings or hypocaloric diets until the diarrhea clears. METHODS: Medical records were retrospectively reviewed, and the literature was reviewed. RESULTS: Severe malnutrition occurred in two children with diarrhea and vomiting who were treated with clear liquids followed by restricted nutrient intake. CONCLUSION: Severe malnutrition associated with diarrhea and vomiting can occur when the prescribed treatment is bowel rest followed by hypocaloric diets until diarrhea clears. Malnutrition can be prevented if the focus of treatment is on nutritional requirements. Current American Academy of Pediatrics recommendations for treatment of diarrhea and vomiting are discussed.


Subject(s)
Diarrhea/therapy , Energy Intake , Nutrition Disorders/etiology , Nutritional Requirements , Vomiting/therapy , Child, Preschool , Diarrhea/complications , Enteral Nutrition , Female , Humans , Infant , Male , Nutrition Disorders/prevention & control , Parenteral Nutrition , Vomiting/complications
14.
Peptides ; 19(3): 495-504, 1998.
Article in English | MEDLINE | ID: mdl-9533637

ABSTRACT

Degradation of epidermal growth factor (EGF) in human gastric and duodenal lumen was analyzed by incubating 125I-labeled or unlabeled human recombinant EGF with human gastric or duodenal luminal fluids in vitro. Degradation of EGF was assessed by measuring the generation of acid soluble radioactivity or by reversed-phase high-performance liquid chromatography (HPLC). Incubation with gastric luminal fluids resulted in a time- and dose-dependent degradation of labeled and unlabeled EGF at pH 2.5 but not at pH 7.5. Duodenal luminal fluids, on the other hand, degraded EGF at pH 7.5 but not at pH 2.5. The rate of degradation of unlabeled EGF in gastric luminal fluids was nearly 12-fold higher than the rate of degradation of labeled EGF, whereas only a slight difference in rates of degradation of labeled and unlabeled EGF was observed in duodenal luminal fluids. High-performance liquid chromatography analysis detected three major degradation products that eluted with retention time of 17.5 min, 20.0 min, and 22.5 min that was associated with a reduction of intact EGF (retention time 23.5 min). Defatted and decaseinated supernatant of bovine milk effectively inhibited the degradation of EGF in both gastric and duodenal luminal fluids. Dietary derived protease inhibitors, such as soya bean trypsin inhibitor, lima bean trypsin inhibitor, egg white protease inhibitor, and Bowman-Birk protease inhibitor prevented EGF degradation in duodenal luminal fluids but failed to inhibit EGF degradation in gastric luminal fluids. These results suggest that bovine milk may contain specific inhibitors that protect EGF from proteolytic degradation in human gastric lumen.


Subject(s)
Duodenum/metabolism , Epidermal Growth Factor/pharmacology , Gastric Mucosa/metabolism , Milk Proteins/pharmacology , Milk/metabolism , Adolescent , Animals , Dietary Proteins/pharmacology , Humans , In Vitro Techniques , Protease Inhibitors/pharmacology
16.
Am J Physiol ; 273(4): G812-23, 1997 10.
Article in English | MEDLINE | ID: mdl-9357822

ABSTRACT

The effect of hydrogen peroxide (H2O2) on intestinal epithelial barrier function was examined in Caco-2 and T84 cell monolayers. H2O2 reduced transepithelial electrical resistance (TER) of Caco-2 and T84 cell monolayers. This decrease in TER was associated with a decrease in dilution potential and an increase in [3H]mannitol permeability, suggesting an H2O2-induced disruption of the paracellular junctional complexes. H2O2 administration also induced tyrosine phosphorylation of several proteins (at the molecular mass ranges of 50-90, 100-130, and 150-180 kDa) in Caco-2 cell monolayers. Phenylarsine oxide and sodium orthovanadate, inhibitors of protein tyrosine phosphatase, decreased TER and increased mannitol permeability and protein tyrosine phosphorylation (PTP). A low concentration of sodium orthovanadate also potentiated the effect of H2O2 on TER, dilution potential, mannitol permeability, and PTP. Pretreatment with genistein (30-300 microM) and tyrphostin (100 microM) inhibited the effect of H2O2 on TER, dilution potential, mannitol permeability, and PTP. These studies show that H2O2 increases the epithelial permeability by disrupting paracellular junctional complexes, most likely by a PTP-dependent mechanism.


Subject(s)
Hydrogen Peroxide/pharmacology , Intestinal Mucosa/physiology , Oxidants/pharmacology , Arsenicals/pharmacology , Bumetanide/pharmacology , Calcium/metabolism , Cell Line , Cell Membrane Permeability/drug effects , Electric Conductivity , Enzyme Inhibitors/pharmacology , Humans , Intestinal Mucosa/drug effects , Kinetics , Mannitol/pharmacokinetics , Membrane Potentials/drug effects , Octoxynol/toxicity , Phosphorylation , Phosphotyrosine/metabolism , Tumor Cells, Cultured , Tyrosine , Vanadates/pharmacology
17.
Ann Plast Surg ; 37(5): 465-8, 1996 Nov.
Article in English | MEDLINE | ID: mdl-8937597

ABSTRACT

Lower eye lid blepharoplasty is a frequent cosmetic procedure. The carbon dioxide laser transconjunctival approach is a popular alternative to conventional techniques. Eight hundred eighty-nine consecutive cases were studied retrospectively to determine the occurrence of complications. All cases were included. Complications were divided into intraoperative, immediate postoperative (days 1-7) and late postoperative (greater than 7 days). Complications encountered in this study of carbon dioxide laser conjunctival blepharoplasty were uncommon and not severe.


Subject(s)
Carbon Dioxide , Eyelids/surgery , Laser Therapy , Postoperative Complications , Adult , Aged , Female , Follow-Up Studies , Humans , Intraoperative Complications , Male , Middle Aged , Retrospective Studies
18.
N Engl J Med ; 334(16): 1062; author reply 1062-3, 1996 Apr 18.
Article in English | MEDLINE | ID: mdl-8598855
19.
J Transcult Nurs ; 7(2): 10-3, 1996.
Article in English | MEDLINE | ID: mdl-8974411

ABSTRACT

The application of Leininger's Theory of Culture Care Diversity and Universality to the dialogue between students and faculty regarding nursing education and practice provides the theoretical framework for evaluating a transcultural nursing curriculum in a transcultural, transnational setting on the Texas-Mexico border. In evaluating the first semester of this cultural encounter between the nurse-patient-community system and baccalaureate nursing education, faculty and students at Texas A&M International University School of Nursing in Laredo identified some particular challenges and assessed the effectiveness of approaches to meeting these challenges within the context of Leininger's Culture Care Theory and its three modes of action: culture care preservation, accommodation, and repatterning.


Subject(s)
Cultural Diversity , Education, Nursing, Baccalaureate/organization & administration , Students, Nursing , Transcultural Nursing/education , Curriculum , Humans , Nursing Theory , Program Evaluation , Texas
20.
Dermatol Surg ; 21(12): 1065-70, 1995 Dec.
Article in English | MEDLINE | ID: mdl-7496677

ABSTRACT

BACKGROUND: Repair of levator aponeurosis pathology has become accepted technique for the correction of acquired ptosis. Extensive experience with carbon dioxide (CO2) laser blepharoplasty has been obtained. OBJECTIVE: CO2 laser blepharoplasty techniques are expanded to repair acquired ptosis. METHODS: A step-wise outline of laser surgical technique is presented. RESULTS: A retrospective serial study of 82 patients is reviewed and compared favorably with other reported series. Improvement in appearance and reduction of asymmetry to less than 1 mm was observed in 69 patients (84%). Thirteen patients had more than 1 mm of asymmetry and eight underwent surgical revisions. No long-term complications such as chronic exposure keratitis were noted. CONCLUSIONS: The CO2 laser repair of acquired ptosis by aponeurotic surgery can be combined with blepharoplasty surgery. Improved intraoperative hemostasis, decreased operating time, and improved appearance in the immediate postoperative period are achieved with this technique.


Subject(s)
Blepharoptosis/surgery , Eyelids/surgery , Laser Therapy/methods , Combined Modality Therapy , Humans , Laser Therapy/instrumentation , Postoperative Care/methods , Reoperation , Retrospective Studies , Suture Techniques
SELECTION OF CITATIONS
SEARCH DETAIL